メニュー

業績

雑誌・WEB

英語論文

  • Kanazu M, Shimokawa M, Saito R,…. Predicting systemic therapy toxicity in older adult patients with advanced non-small cell lung cancer: a prospective multicenter study of National Hospital Organization in Japan. J Geriatr Oncol. 2022
  • Hara R, Kanazu M, Iwai A,…. EGFR-mutant lung adenocarcinoma associated with antisynthetase syndrome successfully treated with osimertinib. Thorac Cancer. 2021
  • Kanazu M, Mori M, Kimura M,…. Effectiveness of EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer patients with uncommon EGFR mutations: a multicenter observational study. Thorac Cancer. 2021
  • Edahiro R, Kanazu M, Krebe H,…. Clinical outcomes in non-small cell lung cancer patients with an ultra-high expression of programmed death ligand-1 using pembrolizumab as a first-line therapy: a retrospective multicenter cohort study in Japan. PLos One. 2019
  • Kanazu M, Edahiro R, Krebe H,…. Hyperprogressive disease in patients with non-small cell lung cancer treated with nivolumab: a case series. Thorac Cancer. 2018
  • Kanazu M, Uenami T, Yano Y,…. Case series of pleomorphic carcinomas of the lung treated with nivolumab. Thorac Cancer. 2017
  • Kanazu M, Maruyama K, Ando M,…. Early Pharmacodynamic assessment using 18F-fluorodeoxyglucose positron-emission tomography on molecular targeted therapy and cytotoxic chemotherapy for clinical outcome prediction. Clin Lung Cancer. 2014
  • Kanazu M, Arai T, Sugimoto C,…. An intractable case of Hermansky-Pudlak syndrome. Intern Med. 2014
  • Kanazu M, Lu Y, Morimoto K. Dual function of (--)-epigallicatechin gallate (EGCG) in healthy human lymphocytes. Cancer Lett. 2006

*筆頭または論文の最終責任者として関わった論文のみ抜粋

▲ ページのトップに戻る

Close

HOME